EFNB2 and neoplasm: Concordant with our previous data, ephrinB2-Fc, ephrinB2-Fc-His, and Fc-TNYL-RAW-GS all significantly reduced local tumor growth, while ephrinB2-Fc-His was the only treatment that yielded a significant improvement in overall survival (Fig. 7B–D).